(Q36860625)

PubMed ID

17592537

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17592537%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Understanding the natural biology of kidney cancer: implications for targeted cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

1 reference

Tobias Klatte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

Allan J Pantuck

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

Mark D Kleid

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

Arie S Belldegrun

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

publication date

1 January 2007

1 reference

PubMed ID

17592537

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17592537%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

page(s)

47-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

9 May 2020

cites work

1 reference

12 December 2020

Inherited susceptibility to uterine leiomyomas and renal cell cancer

1 reference

12 December 2020

Prognostic significance of the mode of detection in renal tumours

1 reference

12 December 2020

Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation

1 reference

12 December 2020

Cytogenetic classification of renal cell cancer

1 reference

12 December 2020

Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas

1 reference

12 December 2020

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

1 reference

12 December 2020

Targeted agents for the treatment of advanced renal cell carcinoma

1 reference

12 December 2020

Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells

1 reference

12 December 2020

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

12 December 2020

Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

1 reference

12 December 2020

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics

1 reference

12 December 2020

Targeting the ERK signaling pathway in cancer therapy

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma.

1 reference

12 December 2020

Overexpression of the met/HGF receptor in renal cell carcinomas

1 reference

12 December 2020

Identification of the von Hippel-Lindau disease tumor suppressor gene

1 reference

12 December 2020

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism.

1 reference

12 December 2020

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

12 December 2020

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

1 reference

12 December 2020

A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma

1 reference

12 December 2020

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

1 reference

12 December 2020

Hereditary Multiple Fibrofolliculomas With Trichodiscomas and Acrochordons

1 reference

12 December 2020

Renal cell carcinoma: prognostic significance of incidentally detected tumors

1 reference

12 December 2020

Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.

1 reference

12 December 2020

Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.

1 reference

12 December 2020

Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors

1 reference

12 December 2020

Growing roles for the mTOR pathway

1 reference

12 December 2020

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

1 reference

12 December 2020

A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma

1 reference

12 December 2020

Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases

1 reference

12 December 2020

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population

1 reference

12 December 2020

Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.

1 reference

12 December 2020

Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours

1 reference

12 December 2020

Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification

1 reference

12 December 2020

Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma

1 reference

12 December 2020

Novel treatments for metastatic renal cell carcinoma

1 reference

12 December 2020

Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.

1 reference

12 December 2020

Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome

1 reference

12 December 2020

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

12 December 2020

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

1 reference

12 December 2020

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

12 December 2020

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study

1 reference

12 December 2020

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

12 December 2020

Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

1 reference

12 December 2020

The current state of renal cell carcinoma grading. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

1 reference

12 December 2020

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

1 reference

12 December 2020

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.

1 reference

12 December 2020

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent.

1 reference

12 December 2020

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

1 reference

12 December 2020

Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma

1 reference

12 December 2020

The changing natural history of renal cell carcinoma

1 reference

12 December 2020

How tumors become angiogenic

1 reference

12 December 2020

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma

1 reference

12 December 2020

C-met proto-oncogene expression in benign and malignant human renal tissues

1 reference

12 December 2020

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway

1 reference

12 December 2020

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

12 December 2020

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

12 December 2020

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

1 reference

12 December 2020

Targeting the c-Met signaling pathway in cancer

1 reference

12 December 2020

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Molecular cytogenetics of renal cell tumors

1 reference

12 December 2020

Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma

1 reference

12 December 2020

A postoperative prognostic nomogram for renal cell carcinoma

1 reference

12 December 2020

Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

1 reference

12 December 2020

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

12 December 2020

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 reference

12 December 2020

Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

1 reference

12 December 2020

Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma

1 reference

12 December 2020

Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene

1 reference

12 December 2020

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

12 December 2020

External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma

1 reference

12 December 2020

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score

1 reference

12 December 2020

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1892626&resulttype=core&format=json

9 May 2020

1 reference